STIMIT Enrolls Patients in Trial for Noninvasive Diaphragm Neurostimulation Device
STIMIT AG announced today that it is enrolling patients in its FDA Investigational Device Exemption (IDE) clinical trial, the “STIMIT ACTIVATOR 1 PIVOTAL STUDY,” in collaboration with leading clinical centers…